Skip to main content
Clinical Trials/ITMCTR2200005690
ITMCTR2200005690
Not yet recruiting
Phase 1

A randomized controlled study of the effect of electro-acupuncture on endometrial blood flow in RIF patients

Chengdu Xinan Gynecological Hospital0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
recurrent implantation failure
Sponsor
Chengdu Xinan Gynecological Hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Chengdu Xinan Gynecological Hospital

Eligibility Criteria

Inclusion Criteria

  • (1\) Aged between 22 to 40 female.
  • (2\) Meeting the diagnostic criteria for recurrent implantation failure.
  • (3\) The availability of frozen embryos and prepare for FET .
  • (4\) Patients undergoing endometrial preparation using a hormone replacement therapy or Gnrh\-a down regulation hormone replacement therapy.
  • (5\)Patients with endometrial flow type II or type I.
  • (6\) Signed an informed consent form.
  • Note: Patients meeting all 6 criteria above were included in this study.

Exclusion Criteria

  • (1\) Ultrasound examination shows unaddressed uterine malformations that clearly affect uterine morphology, uterine fibroids that compress the uterine cavity, or ovarian cysts
  • (2\) Having a clearly diagnosis autoimmune disease or pre\-thrombotic state, such as systemic lupus erythematosus, rheumatoid arthritis, etc.
  • (3\) Having an unsolved endocrine disorder, such as hyperthyroidism, diabetes mellitus, hypertension, etc.
  • (4\) Suffering from a clearly diagnosed medical or surgical serious primary or secondary disease or psychiatric disorder in progress.
  • (5\) Patients with chromosomal abnormalities(Except for chromosome polymorphism).
  • (6\) The patient has a history of assisted reproduction live births
  • (7\) Patients with bleeding tendencies and those prone to infection, or those suffering from severe allergies, or with skin ulcers or scarring that prohibit needling or dizziness.
  • (8\) Patients who have received acupuncture treatment in the last three months.
  • (9\) Patients who are participating in other clinical trials.
  • Note: Anyone who meets any 1 of the above criteria will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials